Warning-
as we can see that Strides Pharma is currently showing a gradual recovery after a volatile phase, with price stabilizing and momentum indicators turning supportive. The stock has transitioned from earlier weakness into a sideways-to-bullish setup, indicating accumulation rather than fresh selling pressure
On the technical front, RSI is hovering around 50–59 levels, which indicates a neutral-to-bullish zone, meaning the stock is gaining strength without being overbought, leaving room for upside expansion . This type of RSI behavior typically supports trend continuation or bounce from base levels.
Disclaimer– Registration granted by SEBI, membership of a SEBI recognized supervisory body (BSE) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Disclosure– Investments in securities market are subject to market risks, read all the related documents carefully before investing.